Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bröske AE"'
Autor:
Kraxner A; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Braun F; Roche Pharma Research and Early Development, Data and Analytics, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Cheng WY; Roche Pharma Research and Early Development, Data and Analytics, Roche Translational & Clinical Research Center, F. Hoffmann-La Roche Ltd, Little Falls, NJ, United States., Yang TO; Roche Pharma Research and Early Development, Data and Analytics, Roche Translational & Clinical Research Center, F. Hoffmann-La Roche Ltd, Little Falls, NJ, United States., Pipaliya S; Roche Pharma Research and Early Development, Data and Analytics, Roche Innovation Center Zurich, Roche Glycart AG, Schlieren, Switzerland., Canamero M; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Andersson E; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Harring SV; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Dziadek S; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Bröske AE; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Ceppi M; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Tanos T; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Teichgräber V; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Charo J; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Zurich, Roche Glycart AG, Schlieren, Switzerland.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jul 05; Vol. 15, pp. 1352632. Date of Electronic Publication: 2024 Jul 05 (Print Publication: 2024).
Autor:
Dziadek S; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Kraxner A; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Cheng WY; Roche Pharma Research and Early Development, Data and Analytics, Roche Translational & Clinical Research Center, F. Hoffmann-La Roche Ltd, Little Falls, NJ, United States., Ou Yang TH; Roche Pharma Research and Early Development, Data and Analytics, Roche Translational & Clinical Research Center, F. Hoffmann-La Roche Ltd, Little Falls, NJ, United States., Flores M; Roche Tissue Diagnostics, Tucson, AZ, United States., Theiss N; Roche Tissue Diagnostics, Tucson, AZ, United States., Tsao TS; Roche Tissue Diagnostics, Tucson, AZ, United States., Andersson E; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Harring SV; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Bröske AE; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Ceppi M; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Teichgräber V; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Charo J; Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Zurich, Roche Glycart AG, Schlieren, Switzerland.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Mar 15; Vol. 15, pp. 1352615. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).
Autor:
Bröske AE; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Korfi K; Roche Innovation Center Zürich, Roche Pharma Research and Early Development, Zürich, Switzerland., Belousov A; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Wilson S; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Ooi CH; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Bolen CR; Genentech, Inc., South San Francisco, CA., Canamero M; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Alcaide EG; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., James I; A4P Consulting Ltd., Sandwich, United Kingdom., Piccione EC; Genentech, Inc., South San Francisco, CA., Carlile DJ; Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn Garden City, United Kingdom; and., Dimier N; Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn Garden City, United Kingdom; and., Umaña P; Roche Innovation Center Zürich, Roche Pharma Research and Early Development, Zürich, Switzerland., Bacac M; Roche Innovation Center Zürich, Roche Pharma Research and Early Development, Zürich, Switzerland., Weisser M; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Dickinson M; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, VIC, Australia.
Publikováno v:
Blood advances [Blood Adv] 2022 Feb 08; Vol. 6 (3), pp. 1025-1037.
Autor:
Hutchings M; Department of Hematology and Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Morschhauser F; Université de Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France., Iacoboni G; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Department of Medicine, Universitat Autònoma of Barcelona, Barcelona, Spain., Carlo-Stella C; Humanitas Clinical and Research Center-IRCCS and Humanitas University, Rozzano, Italy., Offner FC; Ghent University, Ghent, Belgium., Sureda A; Institut Català d'Oncologia-Hospitalet, Institut d'Investigació Biomedica de Bellvitge, Universitat de Barcelona, Barcelona, Spain., Salles G; Hôpital Lyon Sud, Université Claude Bernard Lyon 1, Pierre-Bénite, France., Martínez-Lopez J; Hospital 12 de Octubre, i+12, Complutense University, Centro Nacional de Investigaciones Oncológicas, CRIS Unit, Madrid, Spain., Crump M; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Thomas DN; Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY., Morcos PN; Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY., Ferlini C; Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY., Bröske AE; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Belousov A; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Zurich, Switzerland., Bacac M; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Zurich, Switzerland., Dimier N; Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn Garden City, United Kingdom., Carlile DJ; Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn Garden City, United Kingdom., Lundberg L; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Perez-Callejo D; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Umaña P; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Zurich, Switzerland., Moore T; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Weisser M; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Dickinson MJ; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Jun 20; Vol. 39 (18), pp. 1959-1970. Date of Electronic Publication: 2021 Mar 19.